We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (INTEGRATEIIa)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02773524
Recruitment Status : Active, not recruiting
First Posted : May 16, 2016
Last Update Posted : January 13, 2022
Sponsor:
Collaborators:
Canadian Cancer Trials Group
Academic and Community Cancer Research United
National Health and Medical Research Council, Australia
Information provided by (Responsible Party):
Australasian Gastro-Intestinal Trials Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : December 2022